AI summary Trust: medium Third-party lab

LabE tested this Tirzepatide batch (Blue Cap) at 99.9% purity via HPLC. However, the tested quantity was significantly lower than the label (17.7mg vs 30mg, a -41% deviation). No endotoxin test results were available. The test is recent (under 3 months), and customers can cross-check on the lab's public verification URL.

Watch out for
  • significant quantity deviation
  • no endotoxin test
Test date
2026-03-02
Purity
99.90% 99.90%
Batch / lot
[NAME_REDACTED]
Lab
LabE
Quantity
label 30mg tested 17.7mg
Qty vs label
-41.0%
Endotoxins
n/a
Test score
6.7
Manufacturer
Xingruida Xdr
View vendor dossier
Certificate

Test report image

Certificate scan
Certificate scan as published.
Source

Finnrick

✓ Artifact captured

We have the certificate image (SHA-256 hash captured) — you can verify it loads from the upstream lab and matches the artifact below.

Verify on upstream
Method
HPLC + mass quantification + endotoxins
Test type
finnrick_composite
Dose
30mg
Container
No Label / Silver Crimp / Blue Cap
Catalogued
2026-04-16
Artifact hash
013ee1ba27213159…
This COA is part of TitrateLab's community-trust corpus. See more from Xingruida Xdr or learn how trust scores are computed on the methodology page.